Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone -) is animmunomodulator drug currently used to treat multiple sclerosis. Glatiramer acetate is a random polymer of four amino acids found inmyelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system.
Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is approved for treatment after single episodes. Acetas glatiramer etiam tractabat recidivo-remittentes multiplices sclerosis. Glatiramerus acetas per iniectionem subcutaneam administratur.
Glatiramerus acetas ab Cibus et medicamentis administratione approbatur (FDA) ad reducere frequentia relapsus, sed non reducere progressum vitium. Studiorum observationum, sed non randomized dispensata iudiciis, suadeant ut Glatiramer acetas progressionem vitium reducere possit.
